PLRX — Pliant Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Pliant Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	201	331	494	356	191
Net Total Accounts Receivable
Net Total Receivables	2.08	2.07	3	2.3	0.823
Prepaid Expenses
Total Other Current Assets
Total Current Assets	209	340	506	362	196
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.9	9.91	4.78	32.8	26.9
Other Long Term Assets
Total Assets	221	351	512	397	225
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	16.8	23.9	28.5	33.2	16.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.2	37.3	38.6	92.9	44
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	199	313	474	304	181
Total Liabilities & Shareholders' Equity	221	351	512	397	225
Total Common Shares Outstanding